Establishment of a mathematical prediction model for voriconazole stable maintenance dose: a prospective study
Frontiers in Cellular and Infection Microbiology · 2023
DOI: 10.3389/fcimb.2023.1157944 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2023. Verfasst von Lijuan Zhou und 10 weiteren Autor:innen. Beteiligte Einrichtung: Translational Medicine Center, Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou, Henan, China. Hauptthemen laut MEDLINE: Antifungal Agents, Invasive Fungal Infections. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
In patients with invasive fungal infection (IFI), the steady-state serum trough concentration ( C min ) of voriconazole (VCZ) is highly variable and can lead to treatment failure ( C min < 0.5 mg/L) and toxicity ( C min ≥ 5.0 mg/L). However, It remains challenging to determine the ideal maintenance dose to achieve the desired C min level quickly.
Aims
This randomized, prospective observational single-center study aimed to identify factors affecting VCZ- C min and maintenance dose and create an algorithmic model to predict the necessary maintenance dose. MeThe study enrolled 306 adult IFI patients, split into two groups: non-gene-directed (A) (where CYP2C19 phenotype is not involved in determining VCZ dose) and gene-directed (B) (where CYP2C19 phenotype is involved in determining VCZ dose).
Results
Results indicated that CYP2C19 genetic polymorphisms might significantly impact VCZ loading and maintenance dose selection. CYP2C19 phenotype, C-reaction protein (CRP), and average daily dose/body weight were significant influencers on VCZ- C min , while CYP2C19 phenotype, CRP, and body weight significantly impacted VCZ maintenance dose. A feasible predictive formula for VCZ stable maintenance dose was derived from the regression equation as a maintenance dose (mg) =282.774-0.735×age (year)+2.946×body weight(Kg)-19.402×CYP2C19 phenotype (UM/RM/NM:0, IM:1, PM:2)-0.316×CRP (mg/L) ( p < 0.001).
Discussion
DiThis formula may serve as a valuable supplement to the Clinical Pharmacogenetics Implementation Consortium (CPIC ® ) guideline for CYP2C19 and VCZ therapy, especially for IFI patients with highly variable inflammatory cytokines during VCZ therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Translational Medicine Center, Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou, Henan, China.
- Department of Hematology, Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou, Henan, China.
- Department of Respiratory Medicine, Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou, Henan, China.
- College of Pharmacy, Xinxiang Medical University, Xinxiang, Henan, China.
- Institutes of Biomedical Sciences and Children's Hospital, Fudan University, Shanghai, China.
- College of Nursing, Chifeng University, Chifeng, Inner Mongolia, China.
Zitieren
APA
Zhou, L., Li, M., Li, H., Guo, Z., Gao, Y., Zhang, H., Qin, F., Sang, Z., Xing, Q., Cheng, L., & Cao, W. (2023). Establishment of a mathematical prediction model for voriconazole stable maintenance dose: a prospective study. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2023.1157944
Vancouver
Zhou L, Li M, Li H, Guo Z, Gao Y, Zhang H, et al. Establishment of a mathematical prediction model for voriconazole stable maintenance dose: a prospective study. Frontiers in Cellular and Infection Microbiology. 2023. doi:10.3389/fcimb.2023.1157944
BibTeX
@article{Zhou2023,
author = {Zhou, Lijuan and Li, Min and Li, Huihong and Guo, Zhiqiang and Gao, Yanqiu and Zhang, Hua and Qin, Fuli and Sang, Zhihui and Xing, Qinghe and Cheng, Long and Cao, Wei},
title = {Establishment of a mathematical prediction model for voriconazole stable maintenance dose: a prospective study},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2023},
doi = {10.3389/fcimb.2023.1157944}
}
EUVIMED